.After declaring a stage 3 launch based on beneficial midstage outcomes, iTeos and GSK are finally d...
.The FDA ought to be actually extra available and collective to unleash a surge in approvals of unco...
.It is actually an uncommonly hectic Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara T...
.Atea Pharmaceuticals' antiviral has actually stopped working one more COVID-19 trial, however the b...
.Neurocrine Biosciences' mental illness course pivot has actually neglected. The biotech was actuall...
.Sanofi has actually created a late access to the radioligand event, paying out 100 thousand europea...
.After F2G's initial try to acquire a brand-new course of antifungal to market was wrecked due to th...
.Moderna has actually promised to reduce R&D costs by $1.1 billion by 2027. The decision to shrin...
.Merely 4 months after Sanofi bet $80 million in ahead of time money on Key Rehabs' losmapimod, the ...
.Cancer cells company Oncternal Therapies is folding all its clinical tests and also laying off staf...